For full functionality, including active links, we recommend downloading the PDF. Certain interactive features may not operate within the embedded viewer.
Download this PDF file

 

Crossref Citations

1. Prevalence and Seroprevalence of Non-SARS Human Coronaviruses 229E and OC43 in East Tyrol/Austria
Sonnleitner Stefanie, Sonnleitner Sissy, Eva Hinterbichler, Gernot Walder
Journal of Biosciences and Medicines  vol: 11  issue: 07  first page: 125  year: 2023  
doi: 10.4236/jbm.2023.117011

2. The clinical and virological features of two children's coinfections with human adenovirus type 7 and human coronavirus-229E virus
Shelan Liu, An Zhu, Jinren Pan, Lihong Ying, Wanwan Sun, Hanting Wu, Haiying Zhu, Haiyan Lou, Lan Wang, Shuwen Qin, Zhao Yu, Jian Cai, Yin Chen, Enfu Chen
Frontiers in Public Health  vol: 10  year: 2022  
doi: 10.3389/fpubh.2022.1048108

3. Emerging Infectious Diseases and the Eye: Ophthalmic Manifestations, Pathogenesis, and One Health Perspectives
K’Mani Blyden, Joanne Thomas, Parisa Emami-Naeini, Tolulope Fashina, Christopher D. Conrady, Thomas A. Albini, Jessica Carag, Steven Yeh
International Ophthalmology Clinics  vol: 64  issue: 4  first page: 39  year: 2024  
doi: 10.1097/IIO.0000000000000539

4. Alpha- and Beta-Coronaviruses in Humans and Animals: Taxonomy, Reservoirs, Hosts, and Interspecies Transmission
Bekbolat Usserbayev, Kuandyk Zhugunissov, Izat Smekenov, Nurlan Akmyrzayev, Akbope Abdykalyk, Khayrulla Abeuov, Balnur Zhumadil, Aibarys Melisbek, Meirzhan Shirinbekov, Samat Zhaksylyk, Zhanerke Nagymzhanova, Ainur Seidakhmetova, Chiara Beltramo, Simone Peletto, Aslan Kerimbaev, Sergazy Nurabaev, Olga Chervyakova, Nurlan Kozhabergenov
Microorganisms  vol: 14  issue: 1  first page: 43  year: 2025  
doi: 10.3390/microorganisms14010043

5. Comparison of nanotechnology research for coronaviruses and influenza from 2000 to 2022
Thomas S. Woodson, Swaneet Jha
Journal of Nanoparticle Research  vol: 25  issue: 9  year: 2023  
doi: 10.1007/s11051-023-05831-1

6. Establishment of a human organoid-based evaluation system for assessing interspecies infection risk of animal-borne coronaviruses
Qianchun Gong, Rendi Jiang, Lina Ji, Haofeng Lin, Meiqin Liu, Xiaofang Tang, Yong Yang, Wei Han, Jing Chen, Zishuo Guo, Qi Wang, Qian Li, Xi Wang, Tingting Jiang, Shizhe Xie, Xinglou Yang, Peng Zhou, Zhengli Shi, Xinhua Lin
Emerging Microbes & Infections  vol: 13  issue: 1  year: 2024  
doi: 10.1080/22221751.2024.2327368

7. Human lung organoids as a model for respiratory virus replication and countermeasure performance in human hosts
Caitlin E. Edwards, Aleksandra Tata, Ralph S. Baric
Translational Research  vol: 250  first page: 36  year: 2022  
doi: 10.1016/j.trsl.2022.07.002

8. The Indispensable Value of Small-Molecule Antivirals in Epidemic and Pandemic Preparedness
Ruxandra Draghia-Akli, Nina M Hill, Bruce Altevogt, Kenneth Bradley, Kelly Chibale, Tomas Cihlar, Barry Clinch, James F Demarest, Johan Neyts
Clinical Infectious Diseases  vol: 82  issue: 1  first page: e49  year: 2026  
doi: 10.1093/cid/ciaf476

9. Co-infection of SARS-CoV-2 with human coronavirus OC43 in a patient with underlying lung disease: A case report
Kwadwo Mponponsuo, Yamini Murthy, Jamil Kanji, Alain Tremblay, Daniyal Khan, John Conly, Ranjani Somayaji
Journal of the Association of Medical Microbiology and Infectious Disease Canada  vol: 8  issue: 2  first page: 150  year: 2023  
doi: 10.3138/jammi-2022-0030

10. Advances in the development of infectious clones of human coronaviruses and related applications
Guanya Liu, Ruixiao Tan, Yiyi Wu, Mengwei Wang, Baoying Huang, Wenjie Tan
Biosafety and Health  vol: 7  issue: 1  first page: 59  year: 2025  
doi: 10.1016/j.bsheal.2025.01.003

11. Rapid Discovery of Potent Neutralizing Antibodies against SARS-CoV-2 through Directed Evolution of SARS-CoV-1 Antibodies
Inji Jung, Dinesh Kumar Sriramulu, Jeong Hyeon Yoon, Jisun Lee, Tae Woo Kim, Dae-Hyuk Kweon, Sun-Gu Lee, Sang Taek Jung
Molecular Pharmaceutics  vol: 22  issue: 9  first page: 5316  year: 2025  
doi: 10.1021/acs.molpharmaceut.4c01169

12. Evolution and Control of COVID-19 Epidemic in Hong Kong
Shuk-Ching Wong, Albert Ka-Wing Au, Janice Yee-Chi Lo, Pak-Leung Ho, Ivan Fan-Ngai Hung, Kelvin Kai-Wang To, Kwok-Yung Yuen, Vincent Chi-Chung Cheng
Viruses  vol: 14  issue: 11  first page: 2519  year: 2022  
doi: 10.3390/v14112519

13. Cross-species transmission, evolution and zoonotic potential of coronaviruses
Qian Li, Taif Shah, Binghui Wang, Linyu Qu, Rui Wang, Yutong Hou, Zulqarnain Baloch, Xueshan Xia
Frontiers in Cellular and Infection Microbiology  vol: 12  year: 2023  
doi: 10.3389/fcimb.2022.1081370

14. An overview on the seven pathogenic human coronaviruses
Mina Mobini Kesheh, Parastoo Hosseini, Saber Soltani, Milad Zandi
Reviews in Medical Virology  vol: 32  issue: 2  year: 2022  
doi: 10.1002/rmv.2282

15. Bat coronavirus surveillance across different habitats in Yucatán, México
Marco Antonio Jiménez-Rico, Ana Laura Vigueras-Galván, Erika N. Hernández-Villegas, Paola Martínez-Duque, David Roiz, Luisa I. Falcón, Ella Vázquez-Domínguez, Osiris Gaona, Audrey Arnal, Benjamin Roche, Rosa Elena Sarmiento-Silva, Gerardo Suzán
Virology  vol: 603  first page: 110401  year: 2025  
doi: 10.1016/j.virol.2025.110401

16. The Epuyén Outbreak of Hantavirus Pulmonary Syndrome, Argentina, 2018–2019
Olivier Blond
One Health Cases  year: 2023  
doi: 10.1079/onehealthcases.2023.0018

17. Stalling the Enemy: Targeting Nsp13 for Next-Generation SARS-CoV-2 Antivirals
Jose M. Castro, Ryan L. Slack, Yee T. Ong, Huanchun Zhang, Levi B. Gifford, Valentine V. Courouble, Riley M. Aiken, Vishal Shankar, Timothy R. O’Leary, Patrick R. Griffin, Shuiyun Lan, Yuhong Du, Haian Fu, Stefan G. Sarafianos
International Journal of Molecular Sciences  vol: 27  issue: 6  first page: 2587  year: 2026  
doi: 10.3390/ijms27062587

18. After the Hurricane: Anti-COVID-19 Drugs Development, Molecular Mechanisms of Action and Future Perspectives
Hazim Khalifa, Yousef Al Ramahi
International Journal of Molecular Sciences  vol: 25  issue: 2  first page: 739  year: 2024  
doi: 10.3390/ijms25020739

19. Efficacy of Peracetic Acid and Sodium Hypochlorite against SARS-CoV-2 on Contaminated Surfaces
J. N. Morris, M. A. Esseili, Christopher A. Elkins
Applied and Environmental Microbiology  vol: 89  issue: 7  year: 2023  
doi: 10.1128/aem.00622-23

20. Cross-reactivity IgG, viral load, severity and vaccination outcome as an approach for understanding humoral immune response against SARS-CoV-2
Jesus Contreras-Villa, Griselda Rodríguez-Martínez, Israel Parra-Ortega, Mariana Romo-Castillo, Karen Cortés-Sarabia, Zeus Saldaña-Ahuactzi, Alejandro Flores-Alanis, Alfredo Aureoles-Romero, Marcela Salazar-García, James González, Carlos A. Eslava-Campos, Ulises Hernández-Chiñas, Armando Cruz-Rangel, Rosario Morales-Espinosa, Mario Eugenio Cancino-Diaz, Victor M. Luna-Pineda
BMC Infectious Diseases  vol: 25  issue: 1  year: 2025  
doi: 10.1186/s12879-025-12038-3

21. Bioinformatics Insights on Viral Gene Expression Transactivation: From HIV-1 to SARS-CoV-2
Roberto Patarca, William A. Haseltine
International Journal of Molecular Sciences  vol: 25  issue: 6  first page: 3378  year: 2024  
doi: 10.3390/ijms25063378

22. Bioelectrochemical Sensing Dynamics of SARS-CoV-2 Biomarkers
Nelia A. Sanga, Marlon Oranzie, Jaymi L. January, Meleskow Cox, Kaylin C. Januarie, Candice Cupido, Oluwakemi O. Tovide, Keagan Pokpas, Samantha F. Douman, Emmanuel I. Iwuoha
Bioelectrochemistry  vol: 172  first page: 109368  year: 2026  
doi: 10.1016/j.bioelechem.2026.109368

23. The effectiveness of common household spices and herbs in combating the COVID-19: a review based on experimental and virtual screening
Aisha Saddiqa, Usman Shazad, Sundas Arshad
Journal of Herbal Medicine  vol: 46  first page: 100887  year: 2024  
doi: 10.1016/j.hermed.2024.100887

24. Persistence and free chlorine disinfection of human coronaviruses and their surrogates in water
Mengyang Zhang, Michelle Wei Leong, William A. Mitch, Catherine A. Blish, Alexandria Boehm, Christopher A. Elkins
Applied and Environmental Microbiology  vol: 90  issue: 4  year: 2024  
doi: 10.1128/aem.00055-24

25. Antiviral drug repurposing: different approaches and the case of antifungal drugs
Sara Tuci, Beatrice Mercorelli, Arianna Loregian
Pharmacology & Therapeutics  vol: 273  first page: 108903  year: 2025  
doi: 10.1016/j.pharmthera.2025.108903

26. Prevalence and association of oral manifestations with disease severity in patients diagnosed with COVID‑19: A cross‑sectional study
Adriana-Teodora Campeanu, Mihaela Rus, Sorina Ispas, Alexandra Herlo, Aurora Craciun, Constantin Ionescu, Gheorghe-Mihail Banariu, Claudia-Simona Cambrea, Maria Nicolae, Andreea Nelson‑Twakor, Irina-Magdalena Dumitru
Medicine International  vol: 4  issue: 3  year: 2024  
doi: 10.3892/mi.2024.154

27. TMPRSS2 and glycan receptors synergistically facilitate coronavirus entry
Haofeng Wang, Xiaoce Liu, Xiang Zhang, Zhuoqian Zhao, Yuchi Lu, Dingzhe Pu, Zeyang Zhang, Jie Chen, Yajie Wang, Mengfei Li, Xuxue Dong, Yinkai Duan, Yujia He, Qiyu Mao, Hangtian Guo, Haoran Sun, Yihan Zhou, Qi Yang, Yan Gao, Xiuna Yang, Hongzhi Cao, Luke Guddat, Lei Sun, Zihe Rao, Haitao Yang
Cell  vol: 187  issue: 16  first page: 4261  year: 2024  
doi: 10.1016/j.cell.2024.06.016

28. The Evolutionary Dance between Innate Host Antiviral Pathways and SARS-CoV-2
Saba R. Aliyari, Natalie Quanquin, Olivier Pernet, Shilei Zhang, Lulan Wang, Genhong Cheng
Pathogens  vol: 11  issue: 5  first page: 538  year: 2022  
doi: 10.3390/pathogens11050538

29. Epidemiological state, patient’s characteristics, and COVID-19 vaccination levels in Algeria
Nour Chems El Houda Khennouchi, Laarem Meradi, Rania Hacini, Rahma Anfal Saighi, Manal Yahiaoui
South Florida Journal of Health  vol: 4  issue: 1  first page: 225  year: 2023  
doi: 10.46981/sfjhv4n1-018

30. Utilizing Rapid Hydrogen Peroxide Generation from 6-Hydroxycatechol to Design Moisture-Activated, Self-Disinfecting Coating
Fatemeh Razaviamri, Sneha Singh, James Manuel, Zhongtian Zhang, Lynn M. Manchester, Caryn L. Heldt, Bruce P. Lee
ACS Applied Materials & Interfaces  vol: 16  issue: 21  first page: 26998  year: 2024  
doi: 10.1021/acsami.4c00213